Company Presentation

RNS Number : 0900P
Advanced Medical Solutions Grp PLC
09 July 2010

9 July 2010


Advanced Medical Solutions Group plc 

(“AMS” or “the Company”)


Company Presentation


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, will today be hosting a research and development presentation for analysts and press.


No new material information will be disclosed during the presentation which will be available today to download from 13.00 on AMS’s website:


ends –


For further information, please visit or contact:


Advanced Medical Solutions Group plc

Don Evans, Chief Executive Officer                                                              Tel: +44 (0) 1606 545508

Mary Tavener, Finance Director

Chris Meredith, Chief Operating Officer


Tavistock Communications

John West / Chris Munden                                                                         Tel: +44 (0) 20 7920 3150


Investec Bank plc

Gary Clarence / Daniel Adams                                                                    Tel: +44 (0) 20 7597 5970


Notes to Editors:


AMS advanced woundcare products are based on an extensive range of technologies including alginates, silver alginates and hydrophilic polyurethane foam. These and other products pioneer the concept of moist wound healing, allowing wounds to heal faster and with less pain and scarring. They protect the wound, deal with tissue fluids and provide an optimal environment for healing to occur. Silver is widely recognised as a safe and effective broad-spectrum anti-microbial agent for infection control.


AMS wound closure and sealants products are based on cyanoacrylate adhesive technology developed for medical applications. Tissue adhesives offer significant benefits over conventional ways of closing wounds following trauma or surgical incision. They are simple to use, non-invasive, help to reduce the risk of infection, minimise trauma to the patient and provide good clinical and cosmetic outcomes. The technology is also ideally suited to protecting skin from breakdown or for use as a skin sealant to help prevent infection of surgical sites.


This information is provided by RNS
The company news service from the London Stock Exchange